搜索医生

John P. Bois, M.D.

  1. Cardiologist
预约门诊

出版物

  1. Sykora D, Olson N, Churchill R, Kim BM, Bratcher M, Elwazir M, Young K, Ryan S, Brodin M, Anderson J, Saunders J, Ezzeddine OA, Bois J, Giudicessi J, Cooper L, Rosenbaum A. A Pharmacist Medication Titration Program for Patients with Cardiac Sarcoidosis and Systolic Heart Failure: A Retrospective Cohort Study. J Am Heart Assoc. 2024 Nov 18; e038965 [Epub ahead of print]
    View PubMed
  2. Ismayl M, Raphael CE, Prasad A, Chareonthaitawee P, Bois JP. Agreement of Doppler Flow Velocity Reserve With PET Flow Reserve in Patients With Angina Without Obstructive Coronary Arteries. Mayo Clin Proc. 2024 Nov 12 [Epub ahead of print]
    View PubMed
  3. Sykora D, Rosenbaum AN, Churchill RA, Kim BM, Elwazir MY, Bois JP, Giudicessi JR, Bratcher M, Young KA, Ryan SM, Sugrue AM, Killu AM, Chareonthaitawee P, Kapa S, Deshmukh AJ, Abou Ezzeddine OF, Cooper LT, Siontis KC. Arrhythmic manifestations and outcomes of definite and probable cardiac sarcoidosis. Heart Rhythm. 2024 Oct; 21 (10):1978-1986 Epub 2024 Apr 06
    View PubMed
  4. Sykora D, Bratcher M, Churchill R, Kim BM, Elwazir M, Young K, Ryan S, Kolluri N, Abou Ezzeddine O, Bois J, Giudicessi J, Cooper L, Rosenbaum A. Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure. Circ J. 2024 Sep 3 Epub 2024 Sept 03
    View PubMed
  5. Saric P, Bois JP, Giudicessi JR, Rosenbaum AN, Kusmirek JE, Lin G, Chareonthaitawee P. Imaging of Cardiac Sarcoidosis: An Update and Future Aspects. Semin Nucl Med. 2024 Sep; 54 (5):701-716 Epub 2024 Mar 12
    View PubMed
  6. Kim BM, Sykora D, Rosenbaum AN, Ahmed E, Churchill RA, Bratcher M, Elwazir MY, Bois JP, Giudicessi JR, Sugrue AM, Killu AM, Kapa S, Deshmukh AJ, Asirvatham SJ, Cooper LT, Abou Ezzeddine OF, Siontis KC. Arrhythmic prognosis according to left ventricular systolic dysfunction severity in cardiac sarcoidosis. Heart Rhythm. 2024 Aug 28 [Epub ahead of print]
    View PubMed
  7. Howick V JF, Singh J, Saric P, Cooper LT Jr, Bois JP. Myocarditis Associated With Anti-IgLON5 Autoimmune Disease Following Immune Checkpoint Inhibitor Therapy. JACC Case Rep. 2024 Aug 21; 29(16):102467.
    View PubMed
  8. de Melo JF Jr, Mangold KE, Debertin J, Rosenbaum A, Bois JP, Attia ZI, Friedman PA, Deshmukh AJ, Kapa S, Cooper LT, Abou Ezzeddine OF, Siontis KC. Detection of cardiac sarcoidosis with the artificial intelligence-enhanced electrocardiogram. Heart Rhythm. 2024 Aug 8 Epub 2024 Aug 08
    View PubMed
  9. Abdulwadood I, De Melo JF, Scheel RC, Bois JP. Severe Hypertriglyceridemia in a Patient With Metabolic Syndrome and Psoriasis on Risankizumab-Rzaa. JCEM Case Rep. 2024 Jun; 2 (6):luae087 Epub 2024 June 21
    View PubMed
  10. Howick JF 5th, Saric P, Elwazir M, Newman DB, Pellikka PA, Howick AS, O'Horo JC, Cooper LT Jr, Deshmukh AJ, Ganesh R, Hurt R, Gersh B, Bois JP. A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19. Am J Med. 2024 Mar 26. [Epub ahead of print]
    View PubMed
  11. McCollough CH, Rajiah P, Bois JP, Winfree TN, Carter RE, Rajendran K, Williamson EE, Thorne JE, Leng S. Comparison of Photon-counting Detector and Energy-integrating Detector CT for Visual Estimation of Coronary Percent Luminal Stenosis. Radiology. 2023 Dec; 309 (3):e230853
    View PubMed
  12. Churchill R, Sykora D, Castrichini M, Arment C, Myasoedova E, Elwazir M, Bois J, Young K, Rosenbaum A. Clinical Response to Tumor Necrosis Factor-alpha Inhibitor Therapy in the Management of Cardiac Sarcoidosis. Am J Cardiol. 2023 Oct 15; 205:20-27 Epub 2023 Aug 12
    View PubMed
  13. Neves R, Tseng AS, Garmany R, Fink AL, McLeod CJ, Cooper LT, MacIntyre CJ, Homb AC, Rosenbaum AN, Bois JP, Abou Ezzeddine OF, Siontis KC, Pereira NL, Ackerman MJ, Giudicessi JR. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy. Int J Cardiol. 2023 Oct 15; 389:131173 Epub 2023 July 08
    View PubMed
  14. Bois JP, Ayoub C, Geske JB, Wong YW, Abbasi MA, Foley TA, Mulvagh SL, Scott CG, Ommen SR, Pellikka PA. Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy. Mayo Clin Proc Innov Qual Outcomes. 2023 Aug; 7(4):309-319. Epub 2023 Jul 19.
    View PubMed
  15. Young KA, Lyle M, Rosenbaum AN, Chang IC, Lin G, Bois MC, Ezzeddine OFA, Jouni H, Chareonthaitawee P, Kapa S, Grogan M, Cooper LT, Blauwet L, Bois JP. (18)F-FDG/(13)N-ammonia cardiac PET findings in ATTR cardiac amyloidosis. J Nucl Cardiol. 2023 Apr; 30 (2):726-735 Epub 2022 Jan 27
    View PubMed
  16. Sykora D, Young KA, Elwazir MY, Bois JP, Arment CA, Chareonthaitawee P, Kolluri N, Ezzeddine OFA, Cooper LT, Rosenbaum AN. The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis. Am J Cardiol. 2023 Mar 15; 191:84-91 Epub 2023 Jan 18
    View PubMed
  17. Ruddy TD, Al-Mallah M, Arrighi JA, Bois JP, Bluemke DA, Di Carli MF, Dilsizian V, Gropler RJ, Jadvar H, Malhotra S, Pelletier-Galarneau M, Schindler TH, Woodard PK, Chareonthaitawee P. SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association. J Nucl Med. 2023 Jan; 64 (1):149-152 Epub 2022 July 19
    View PubMed
  18. Weerasekare JM, Zhou F, Skolnick AH, Jilaihawi H, Williams MR, Dasari S, McPhail ED, Theis JD, Dao LN, Bois JP, Maleszewski JJ, Bois MC. Amyloid deposition in an explanted bioprosthetic aortic valve: case report and review of the literature. Cardiovasc Pathol 2022 Nov-Dec; 61:107469 Epub 2022 Aug 28
    View PubMed
  19. Shabtaie SA, Sehrawat O, Lee JZ, Cha YM, Mulpuru SK, Kowlgi NG, Siontis KC, Rosenbaum AN, Bois JP, AbouEzzeddine OF, Noseworthy PA, Asirvatham SJ, DeSimone CV, Deshmukh AJ. Cardiac resynchronization therapy response in cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2022 Sep; 33 (9):2072-2080 Epub 2022 Aug 04
    View PubMed
  20. Ruddy TD, Al-Mallah M, Arrighi JA, Bois JP, Bluemke DA, Di Carli MF, Dilsizian V, Gropler RJ, Jadvar H, Malhotra S, Pelletier-Galarneau M, Schindler TH, Woodard PK, Chareonthaitawee P. SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association. Circ Cardiovasc Imaging. 2022 Aug; 15 (8):e014576 Epub 2022 Aug 03
    View PubMed
  21. Ruddy TD, Al-Mallah M, Arrighi JA, Bois JP, Bluemke DA, Di Carli MF, Dilsizian V, Gropler RJ, Jadvar H, Malhotra S, Pelletier-Galarneau M, Schindler TH, Woodard PK, Chareonthaitawee P. SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI. J Cardiovasc Magn Reson. 2022 Jul 19; 24 (1):43 Epub 2022 July 19
    View PubMed
  22. Ruddy TD, Al-Mallah M, Arrighi JA, Bois JP, Bluemke DA, Di Carli MF, Dilsizian V, Gropler RJ, Jadvar H, Malhotra S, Pelletier-Galarneau M, Schindler TH, Woodard PK, Chareonthaitawee P. SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI. J Nucl Med. 2022 Jul 19 Epub 2022 July 19
    View PubMed
  23. Elwazir MY, Bird JG, AbouEzzeddine OF, Chareonthaitawee P, Blauwet LA, Collins JD, Gibbons RJ, Rodriguez-Porcel M, Kamal HM, Abdellah AT, Bois JP. Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging. J Nucl Cardiol. 2022 Jun; 29 (3):1389-1401 Epub 2021 Jan 20
    View PubMed
  24. Elwazir MY, Bois JP, Chareonthaitawee P. Utilization of cardiac imaging in sarcoidosis. Expert Rev Cardiovasc Ther. 2022 Apr; 20 (4):253-266 Epub 2022 May 01
    View PubMed
  25. Corban MT, Toya T, Albers D, Sebaali F, Lewis BR, Bois J, Gulati R, Prasad A, Best PJM, Bell MR, Rihal CS, Prasad M, Ahmad A, Lerman LO, Solseth ML, Winters JL, Dietz AB, Lerman A. IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries. Circ Res. 2022 Feb 4; 130 (3):326-338 Epub 2021 Dec 20
    View PubMed
  26. Elwazir M, Krause ML, Bois JP, Christopoulos G, Kendi AT, Cooper JLT, Jouni H, AbouEzzeddine OF, Chareonthaitawee P, Abdelshafee M, Amin S. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience. J Card Fail. 2022 Feb; 28(2):247-258. Epub 2021 Jul 25.
    View PubMed
  27. Kolluri N, Schmidt TJ, Elwazir MY, Kapa S, Abou Ezzeddine OF, Bois JP, Schirger JA, Rosenbaum AN, Cooper LT. Routine Laboratory Biomarkers As Prognostic Indicators of Cardiac Sarcoidosis Outcomes. Sarcoidosis Vasc Diffuse Lung Dis. 2022; 39 (3):e2022023 Epub 2022 Sept 23
    View PubMed
  28. Ezzeddine FM, Kapa S, Rosenbaum A, Blauwet L, Deshmukh AJ, AbouEzzeddine OF, Maleszewski JJ, Asirvatham SJ, Bois JP, Schirger JA, Chareonthaitawee P, Siontis KC. Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes. J Cardiovasc Electrophysiol. 2021 Sep; 32 (9):2486-2495 Epub 2021 Aug 09
    View PubMed
  29. Rosenbaum AN, Kolluri N, Elwazir MY, Kapa S, Abou Ezzeddine OF, Bois JP, Chareonthaitawee P, Schmidt TJ, Cooper LT. Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease. Int J Cardiol. 2021 Jul 15; 335:66-72 Epub 2021 Apr 18
    View PubMed
  30. Kolluri N, Elwazir MY, Rosenbaum AN, Maklady FA, AbouEzzeddine OF, Kapa S, Blauwet LA, Chareonthaitawee P, McBane RD 2nd, Bois JP. Effect of Corticosteroid Therapy in Patients With Cardiac Sarcoidosis on Frequency of Venous Thromboembolism. Am J Cardiol. 2021 Jun 15; 149:112-118 Epub 2021 Mar 20
    View PubMed
  31. Christopoulos G, Jouni H, Acharya GA, Blauwet LA, Kapa S, Bois J, Chareonthaitawee P, Rodriguez-Porcel MG. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol. J Nucl Cardiol. 2021 Apr; 28 (2):661-671 Epub 2019 May 20
    View PubMed
  32. Elwazir MY, Bois JP, Abou Ezzeddine OF, Chareonthaitawee P. Imaging and Quantification of Cardiac Sarcoidosis. Semin Nucl Med. 2020 Jul; 50 (4):283-294 Epub 2020 Apr 25
    View PubMed
  33. Garcia MJ, Kwong RY, Scherrer-Crosbie M, Taub CC, Blankstein R, Lima J, Bonow RO, Eshtehardi P, Bois JP, American Heart Association Council on Cardiovascular Radiology and Intervention and Council on Clinical Cardiology. State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association. Circ Cardiovasc Imaging. 2020 Jul; 13 (7):e000053 Epub 2020 July 13
    View PubMed
  34. Toya T, Corban MT, Imamura K, Bois JP, Gulati R, Oh JK, Lerman LO, Lerman A. Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction. Atherosclerosis. 2020 Jun; 302:27-35 Epub 2020 Apr 29
    View PubMed
  35. Christopoulos C, Bois JP, Kemp BJ, Askew JW, Rodriguez-Porcel M, Gibbons RJ, Johnson GB, Chareonthatawee P. Comparison of Maximal Hyperemic Myocardial Blood Flow Response between regadenoson and adenosine Nuclear Medicine and Biomedical Imaging. 2020.
  36. Elwazir MY, Bois JP, Abouezzeddine OF, Chareonthaitawee P. Imaging cardiac sarcoidosis and infiltrative diseases: diagnosis and therapeutic response. Q J Nucl Med Mol Imaging. 2020 Mar; 64 (1):51-73 Epub 2020 Jan 24
    View PubMed
  37. Corban MT, Khorramirouz R, Yang SW, Lewis BR, Bois J, Foley T, Lerman LO, Oh JK, Lerman A. Non-infarct related artery microvascular obstruction is associated with worse persistent diastolic dysfunction in patients with revascularized ST elevation myocardial infarction. Int J Cardiol. 2020 Feb 1; 300:27-33 Epub 2019 Oct 07
    View PubMed
  38. Bois JP, Anand V, Anavekar NS. Detection of Inflammatory Aortopathies Using Multimodality Imaging. Circ Cardiovasc Imaging. 2019 Jul; 12 (7):e008471 Epub 2019 July 11
    View PubMed
  39. Bois JP, Muser D, Chareonthaitawee P. PET/CT Evaluation of Cardiac Sarcoidosis. PET Clin. 2019 Apr; 14 (2):223-232 Epub 2019 Feb 01
    View PubMed
  40. Newman DB, Bois JP, Geske JB. Evaluation of the patient with incidental left ventricular hypertrophy on echocardiography Cardiovascular Innovations And Applications. 2019 Apr 1; 4 (1):43-51
  41. Bois JP, Chareonthaitawee P. Patient page-sarcoidosis imaging. J Nucl Cardiol. 2019 Feb; 26 (1):222-226 Epub 2017 Nov 01
    View PubMed
  42. Christopoulos G, Bois J, Allison TG, Rodriguez-Porcel M, Chareonthaitawee P. The impact of combined cardiopulmonary exercise testing and SPECT myocardial perfusion imaging on downstream evaluation and management. J Nucl Cardiol. 2019 Feb; 26 (1):92-106 Epub 2017 May 15
    View PubMed
  43. Bois JP, Scott C, Chareonthaitawee P, Gibbons RJ, Rodriguez-Porcel M. Phase analysis single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) detects dyssynchrony in myocardial scar and increases specificity of MPI. EJNMMI Res. 2019 Jan 31; 9 (1):11
    View PubMed
  44. Wan SH, McKie PM, Bois JP. A Contemporary Systematic Approach to Assessing the Patient with Heart Failure with Reduced Ejection Fraction: Multimodal Noninvasive and Invasive Evaluation. Cardiol Res Pract. 2019; 2019:3039740 Epub 2019 Sept 11
    View PubMed
  45. Khorramirouz R, Corban MT, Yang SW, Lewis BR, Bois J, Foley T, Lerman LO, Herrmann J, Oh JK, Lerman A. Microvascular obstruction in non-infarct related coronary arteries is an independent predictor of major adverse cardiovascular events in patients with ST segment-elevation myocardial infarction. Int J Cardiol. 2018 Dec 15; 273:22-28 Epub 2018 Aug 16
    View PubMed
  46. Maleszewski JJ, Bois MC, Bois JP, Young PM, Stulak JM, Klarich KW. Neoplasia and the Heart: Pathological Review of Effects With Clinical and Radiological Correlation. J Am Coll Cardiol. 2018 Jul 10; 72 (2):202-227
    View PubMed
  47. Bois JP, Gropler RJ, Peterson LR. Contemporary Advances in Myocardial Metabolic Imaging and Their Impact on Clinical Care: a Focus on Positron Emission Tomography (PET) Current Cardiovascular Imaging Reports. 2018.
  48. Kebed DT, Bois JP, Connolly HM, Scott CG, Bowen JM, Warrington KJ, Makol A, Greason KL, Schaff HV, Anavekar NS. Spectrum of Aortic Disease in the Giant Cell Arteritis Population. Am J Cardiol. 2018 Feb 15; 121 (4):501-508 Epub 2017 Nov 23
    View PubMed
  49. Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M. Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive 99mTechnetium-Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis. Circ Cardiovasc Imaging. 2018 Jan; 11(1).
    View PubMed
  50. Vaidya VR, Prueksaritanond S, Bois JP, Nadipalli A, Borgeson DD, Melduni RM. Impact of acute left ventricular apical thrombus on cardioversion for atrial fibrillation. Echocardiography. 2017 Nov; 34 (11):1708-1711 Epub 2017 Sept 24
    View PubMed
  51. Bois JP, Crowson CS, Khullar T, Achenbach SJ, Krause ML, Mankad R. Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis. Echocardiography. 2017 Oct; 34 (10):1410-1416 Epub 2017 Aug 25
    View PubMed
  52. Bois JP, Chareonthaitawee P. Continuing evolution in preparation protocols for (18)FDG PET assessment of inflammatory or malignant myocardial disease. J Nucl Cardiol 2017 Jun; 24 (3):989-992 Epub 2016 Mar 25
    View PubMed
  53. Bois MC, Bois JP, Mankad SV, Young PM, Maleszewski JJ. Retained surgical sponge. Cardiovasc Pathol. 2017 Mar - Apr; 27:43-44 Epub 2017 Jan 10
    View PubMed
  54. Bois JP, Geske JB, Foley TA, Ommen SR, Pellikka PA. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. Am J Cardiol. 2017 Feb 15; 119: (4)643-650.
    View PubMed
  55. Chareonthaitawee P, Bois JP, Gersh BJ. Quantitative Assessment of Myocardial Blood Flow in Cardiac Sarcoidosis: A Potential Next Step in the Further Integration of FDG-PET in Imaging Management? JACC Cardiovasc Imaging 2017 Feb; 10 (2):168-170 Epub 2017 Jan 18
    View PubMed
  56. Bois JP, Glockner J, Young PM, Foley TA, Sheldon S, Newman DB, Lin G, Packer DL, Brady PA. Low incidence of left atrial delayed enhancement with MRI in patients with AF: a single-centre experience. Open Heart. 2017; 4 (1):e000546 Epub 2017 Jan 09
    View PubMed
  57. Illman JE, Maleszewski JJ, Byrne SC, Gotway MB, Kligerman SJ, Foley TA, Young PM, Bois JP, Malik N, Morris JM, Araoz PA. Multimodality imaging of foreign bodies in and around the heart. Future Cardiol. 2016 May; 12 (3):351-71 Epub 2016 May 03
    View PubMed
  58. Bois JP, Waterbury TM, Prasad M, Kebed KY, Tajouri TH, Killu AM, Klarich KW, Connolly HM, Nishimura RA, Oxentenko AS, Ammash NM, Rihal CS, Nagel JJ, Anavekar NS. Coupling Technology With Learning Theory in Curriculum Development: Postgraduate Medical Education at Mayo Clinic. J Grad Med Educ 2016 May; 8 (2):283-4
    View PubMed
  59. Bois JP, Chareonthaitawee P. Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis. J Nucl Cardiol 2016 Apr; 23 (2):253-5 Epub 2015 Aug 13
    View PubMed
  60. Bois JP, Adams JC, Kumar G, Ommen SR, Nishimura RA, Klarich KW. Relation Between Temperature Extremes and Symptom Exacerbation in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 Mar 15; 117 (6):961-5 Epub 2015 Dec 31
    View PubMed
  61. Bois JP, Chareonthaitawee P. Radionuclide Imaging in Congestive Heart Failure: Assessment of Viability, Sarcoidosis, and Amyloidosis. Cardiol Clin. 2016 Feb; 34: (1)119-32.
    View PubMed
  62. Adams JC, Bois JP, Masaki M, Yuasa T, Oh JK, Ommen SR, Nishimura RA, Klarich KW. Postprandial Hemodynamics in Hypertrophic Cardiomyopathy. Echocardiography. 2015 Nov; 32: (11)1614-20.
    View PubMed
  63. Sun PY, Bois JP, Sheldon SH, Asirvatham SJ. Nonobstructive septal hypertrophy in a young adult provoking recurrent polymorphic ventricular tachycardia successfully treated with transaortic and transventricular septal myectomy: A case report. HeartRhythm Case Rep. 2015 Sep; 1 (5):300-304 Epub 2015 May 28
    View PubMed
  64. Bois MC, Bois JP, Anavekar NS, Oliveira AM, Maleszewski JJ. Benign lipomatous masses of the heart: a comprehensive series of 47 cases with cytogenetic evaluation. Hum Pathol. 2014 Sep; 45: (9)1859-65.
    View PubMed
  65. Bois JP, Ponnada VV, O'Cochlain DF, Brady PA, Edwards WD, Klarich KW. Ergotamine-associated valvulopathy with recurrent chylous pleural effusion. Tex Heart Inst J. 2012; 39 (5):736-8
    View PubMed
  66. Bois JP, Valles AG, Sinak LJ. 78-year-old man with metastatic squamous cell carcinoma, dyspnea, and hypotension. Mayo Clin Proc. 2010 Nov; 85 (11):e78-81
    View PubMed
  67. Barton JG, Bois JP, Sarr MG, Wood CM, Qin R, Thomsen KM, Kendrick ML, Farnell MB. Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. J Gastrointest Surg. 2009 Nov; 13 (11):2050-8 Epub 2009 Sept 09
    View PubMed
PST-20389531